This peptide induced the aggregation of VEGFR2, thereby knocking down its function and reducing VEGFR2-dependent growth of tumor allografts of the mouse B16 melanoma line (Figure 2E) (Gallardo et al., 2016). The gene discussed is KDR; the disease is melanoma.